Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Biotechnology Company Announces Partnership With Healthcare Giant Johnson & Johnson

Rallybio and Johnson & Johnson Join Forces to Combat Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT).
In a significant move towards advancing healthcare for the most vulnerable, Rallybio Corporation has announced a groundbreaking collaboration with healthcare giant Johnson & Johnson. This partnership is poised to usher in a new era of therapeutic approaches aimed at mitigating the risks associated with fetal and neonatal alloimmune thrombocytopenia (FNAIT), a rare but potentially life-threatening condition that affects fetuses and newborns. $Rallybio(RLYB.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5014 Views
Comment
Sign in to post a comment
    122Followers
    0Following
    279Visitors
    Follow